Respiratory Distress Syndrome in Premature Infants Clinical Trial
Official title:
Administration of Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation Protocol: A Pilot Trial
This study hopes to determine whether nitric oxide along with oxygen during the first 20 minutes of life in infants needing help with breathing will reduce the percentage and total exposure to oxygen during that time frame. Although the use of oxygen in management of breathing is an important part of supporting baby immediately after delivery, there is more evidence that too much exposure to oxygen may lead to potential problems for your baby later. Oxygen exposure can be harmful to premature babies developing lungs.
Current Neonatal Resuscitation Program (NRP) guidelines suggest the use of supplemental oxygen up to fraction of inspired oxygen of 1.0 during neonatal resuscitation for both term and preterm newborns. Exposure to supplemental oxygen in preterm babies has been shown to have significant toxicity. Even minimal exposure in the first hours of life has been shown to be associated with morbidity including later onset of cancer. The transition from fetal circulation to neonatal circulation is a complex process requiring lung inflation and decrease in pulmonary vascular resistance. Endogenous nitric oxide, along with oxygen, plays a major role in facilitating this transition by decreasing pulmonary vascular resistance. It is not known whether exogenous nitric oxide would facilitate this transition. In this study, we propose a novel approach to resuscitation of preterm infants where inhaled nitric oxide (iNO) will be used as an adjunct to oxygen with the primary goal of reducing supplemental oxygen exposure. This study is designed to be a double-blind, randomized, -placebo- controlled pilot trial with strict monitoring of parameters during transition in the delivery room. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01651637 -
First In Human Study on Synthetic Surfactant CHF 5633 in Respiratory Distress Syndrome
|
Phase 1 | |
| Terminated |
NCT02939742 -
Does a Rescue Course of Betamethasone in Pregnant Women With PPROM Decrease Neonatal Morbidity?
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT04073173 -
Stress Assessment With and Without Analgesia During Surfactant Therapy in Preterm Infants.
|
Phase 4 | |
| Completed |
NCT02770976 -
Respiratory Pattern During Neurally Adjusted Ventilator Assist (NAVA) in Preterm Infants
|
N/A | |
| Completed |
NCT02661256 -
Effect of Nasal Continuous Positive Airway Pressure on The Pharyngeal Swallow in Neonates
|
N/A | |
| Active, not recruiting |
NCT02445040 -
Safety and Efficacy Study of the Draeger Babylog VN500 Device in HFOV Mode in VLBW Neonates
|
N/A | |
| Completed |
NCT01962818 -
High Frequency Oscillatory Ventilation Combined With Intermittent Sigh Breaths: Effects on Lung Volume Monitored by Electric Tomography Impedance.
|
N/A | |
| Completed |
NCT02210026 -
Seattle-PAP Bubble Nasal CPAP and Work of Breathing
|
Phase 1 | |
| Not yet recruiting |
NCT02200900 -
Study of Respiratory Physiology During High Flow Nasal Cannula Treatment in Preterm Neonates.
|
N/A | |
| Completed |
NCT02396693 -
Successful Extubation and Noninvasive Ventilation in Preterm ≤ 1500g Terms
|
N/A |